Unknown

Dataset Information

Systemic autoinflammation with intractable epilepsy managed with interleukin-1 blockade.


ABSTRACT:

Background

Autoinflammatory disorders are distinguished by seemingly random episodes of systemic hyperinflammation, driven in particular by IL-1. Recent pre-clinical work has shown a key role for IL-1 in epilepsy in animal models, and therapies for autoinflammation including IL-1 blockade are proposed for refractory epilepsy.

Case presentation

Here, we report an adolescent female with signs of persistent systemic inflammation and epilepsy unresponsive to multiple anti-epileptic drugs (AED). She was diagnosed with generalized epilepsy with a normal brain MRI and an electroencephalogram (EEG) showing occasional generalized spike and slow wave discharges. Her diagnostic evaluation showed no signs of autoimmunity or genetic causes of epilepsy or periodic fever syndromes but pers

SUBMITTER: DeSena AD 

PROVIDER: S-EPMC5807745 | biostudies-literature | 2018 Feb

REPOSITORIES: biostudies-literature